Nasdaq
AVTX
Avalo Therapeutics, Inc.
- Health Care
- Listed 2015
- 1 day
- −0.7%
- 1 month
- −2.9%
- 1 year
- +125%
$18.70 · Mkt cap $989M
At the 6 Aug 2026 close
Nasdaq
Avalo Therapeutics, Inc.
$18.70 · Mkt cap $989M
At the 6 Aug 2026 close
Avalo Therapeutics, Inc. trades under the ticker AVTX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2015. Its market capitalisation is $989M. The last closing price was $18.70, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +125%, and −2.9% over the past month. Returns are price returns and exclude dividends.
This page exists because AVTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.